Skip to content

Clinical trials

Completed Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Clear all

2,298 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200141
200251
200381
2004123
2005118
2006114
2007127
2008138
2009114
2010116
2011111
2012113
2013109
2014111
201581
201694
201782
201886
201988
202062
202177
202265
202355
202434
202526
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2,298

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.75
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.73
AstraZeneca71
University of Maryland, Baltimore50
Yale University44
VA Office of Research and Development40
Centre for Addiction and Mental Health39
Eli Lilly and Company31
Dartmouth-Hitchcock Medical Center28
Massachusetts General Hospital27

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia2,298
Psychotic Disorders713
Bipolar Disorder223
Mental Disorders141
Major Depressive Disorder72
Hallucinations45
Mood Disorders38
Cognitive Dysfunction37
Metabolic Syndrome36
Obesity34

Trials

Showing 51 to 75 of 2,298. Each trial links to its page on Pharma Observatory.

2,198 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.